New York Times editorial: FDA spying may violate Whistleblower rights

The Food and Drug Administration overstepped its authority in conducting an exhaustive spying campaign on its employees suspected of leaking trade secrets, says a New York Times editorial. Whistleblower identities and any allegations made to appropriate authorities are protected by the Whistleblower Protection Act. -db

From an editorial in The New York Times, July 23, 2012.

Full editorial